Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

689
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
689
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

tRF-17-9L5FZU3 is a novel prognostic biomarker and therapeutic target for esophageal squamous cell carcinoma: mechanisms involving RhoB suppression.

Archives of biochemistry and biophysics·2026
Same author

Disruption of Pik3r1 promotes muscle hyperplasia and lipolysis in grass carp (Ctenopharyngodon idella).

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology·2026
Same author

Balancing optimism versus potential risks of AI-driven drug discovery.

Expert opinion on drug discovery·2026
Same author

PyMolGen: Database-Driven Molecular Generation of Drug-Like Compounds.

Journal of chemical information and modeling·2026
Same author

Proposed Biosynthesis of the Complex Ring-Fused Diterpene Rameswaralide. Mechanistic Insights Using Density Functional Theory.

The Journal of organic chemistry·2026
Same author

Sphingosine-1-Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third-Generation EGFR Inhibitor.

MedComm·2026

相关实验视频

Updated: Jun 18, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K

人工智能用于小分子抗癌药物发现.

Lihui Duo1, Yu Liu1, Jianfeng Ren1

  • 1Faculty of Science and Engineering, University of Nottingham Ningbo China, Ningbo, China.

Expert opinion on drug discovery
|July 29, 2024
PubMed
概括
此摘要是机器生成的。

人工智能 (AI) 和机器学习 (ML) 正在彻底改变小分子癌症药物发现. 这些技术加速了新型抗癌药物的鉴定,克服了传统方法的局限性.

关键词:
药物发现 药物发现人工智能的人工智能是人工智能.癌症 癌症 癌症 癌症 癌症机器学习是机器学习.小分子的小分子.

更多相关视频

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.6K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.7K

相关实验视频

Last Updated: Jun 18, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.6K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.7K

科学领域:

  • 在瘤学瘤学.
  • 药理学 药理学是指药理学的学科.
  • 生物信息学是一种生物信息学.

背景情况:

  • 用小分子向癌症治疗改善了结果,但面临着药物耐药性和低响应率等挑战.
  • 传统的药物发现是耗时和昂贵的,需要更高效的方法.
  • 人工智能 (AI) 和大数据集正在改变小分子抗癌药物发现.

研究的目的:

  • 审查人工智能驱动药物发现的历史里程碑.
  • 突出 AI 在小分子癌症药物发现中的应用.
  • 概述人工智能驱动瘤学的挑战和未来研究方向.

主要方法:

  • 在药物发现中对人工智能应用的审查.
  • 机器学习 (ML) 和深度学习 (DL) 技术的分析.
  • 检查基因组,蛋白质组和成像数据分析.

主要成果:

  • 人工智能能够快速识别和开发新的抗癌药物.
  • 人工智能分析了庞大的数据集,以揭示癌症研究中的隐藏模式.
  • 进步承诺个性化和精确瘤学的突破.

结论:

  • 人工智能正在彻底改变瘤学研究和药物发现.
  • 尽管面临挑战,但人工智能为未来的癌症管理提供了巨大的潜力.
  • 人工智能驱动的方法对于克服向癌症治疗的局限性至关重要.